These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 26827572)

  • 41. Quantitative evaluation of dichloroacetic acid kinetics in human--a physiologically based pharmacokinetic modeling investigation.
    Li T; Schultz I; Keys DA; Campbell JL; Fisher JW
    Toxicology; 2008 Mar; 245(1-2):35-48. PubMed ID: 18242812
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aconitine-containing agent enhances antitumor activity of dichloroacetate against Ehrlich carcinoma.
    Pyaskovskaya ON; Boychuk IV; Fedorchuk AG; Kolesnik DL; Dasyukevich OI; Solyanik GI
    Exp Oncol; 2015 Sep; 37(3):192-6. PubMed ID: 26422103
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition and recovery of rat hepatic glutathione S-transferase zeta and alteration of tyrosine metabolism following dichloroacetate exposure and withdrawal.
    Guo X; Dixit V; Liu H; Shroads AL; Henderson GN; James MO; Stacpoole PW
    Drug Metab Dispos; 2006 Jan; 34(1):36-42. PubMed ID: 16199472
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of lacticacidosis with dichloroacetate.
    Lancet; 1983 Dec; 2(8362):1288-9. PubMed ID: 6139626
    [No Abstract]   [Full Text] [Related]  

  • 45. Dichloroacetate after incomplete ischemia.
    Dimlich RV; Barsan WG
    Stroke; 1987; 18(1):274. PubMed ID: 3810766
    [No Abstract]   [Full Text] [Related]  

  • 46. Dichloroacetate in biguanide-induced lacticacidosis.
    Alberti KG; Nattrass M; Holloway PA
    Lancet; 1977 Nov; 2(8048):1136. PubMed ID: 73048
    [No Abstract]   [Full Text] [Related]  

  • 47. Dichloroacetate and lactic acidosis.
    Kinney EL; Wright RJ
    Ann Intern Med; 1988 Sep; 109(5):435. PubMed ID: 3408060
    [No Abstract]   [Full Text] [Related]  

  • 48. Dichloroacetate, sodium: 3-month oral toxicity studies in rats and dogs.
    Katz R; Tai CN; Diener RM; McConnell RF; Semonick DE
    Toxicol Appl Pharmacol; 1981 Feb; 57(2):273-87. PubMed ID: 7222043
    [No Abstract]   [Full Text] [Related]  

  • 49. Severe encephalopathy and polyneuropathy induced by dichloroacetate.
    Brandsma D; Dorlo TP; Haanen JH; Beijnen JH; Boogerd W
    J Neurol; 2010 Dec; 257(12):2099-100. PubMed ID: 20632025
    [No Abstract]   [Full Text] [Related]  

  • 50. Dichloroacetic acid.
    IARC Monogr Eval Carcinog Risks Hum; 1995; 63():271-90. PubMed ID: 9097096
    [No Abstract]   [Full Text] [Related]  

  • 51. [REPROGRAMMING OF MITOCHONDRIAL ENERGY METABOLISM IN MALIGNANT NEOPLASMS].
    Kaplia AA; Sorokina LV; Khyzhnyak SV
    Ukr Biochem J; 2015; 87(6):19-35. PubMed ID: 27025057
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effectiveness of sodium dichloroacetate against glioma C6 depends on administration schedule and dosage.
    Fedorchuk AG; Pyaskovskaya ON; Gorbik GV; Prokhorova IV; Kolesnik DL; Solyanik GI
    Exp Oncol; 2016 Jun; 38(2):80-3. PubMed ID: 27356574
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Unexpected Discovery of Dichloroacetate Derived Adenosine Triphosphate Competitors Targeting Pyruvate Dehydrogenase Kinase To Inhibit Cancer Proliferation.
    Zhang SL; Hu X; Zhang W; Tam KY
    J Med Chem; 2016 Apr; 59(7):3562-8. PubMed ID: 27006991
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metformin combined with sodium dichloroacetate promotes B leukemic cell death by suppressing anti-apoptotic protein Mcl-1.
    Voltan R; Rimondi E; Melloni E; Gilli P; Bertolasi V; Casciano F; Rigolin GM; Zauli G; Secchiero P
    Oncotarget; 2016 Apr; 7(14):18965-77. PubMed ID: 26959881
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multi-modality imaging to assess metabolic response to dichloroacetate treatment in tumor models.
    Neveu MA; De Preter G; Joudiou N; Bol A; Brender JR; Saito K; Kishimoto S; Grégoire V; Jordan BF; Krishna MC; Feron O; Gallez B
    Oncotarget; 2016 Dec; 7(49):81741-81749. PubMed ID: 28082726
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Glucose Metabolism in Cancer and Ischemia: Possible Therapeutic Consequences of the Warburg Effect.
    Salamon S; Podbregar E; Kubatka P; Büsselberg D; Caprnda M; Opatrilova R; Valentova V; Adamek M; Kruzliak P; Podbregar M
    Nutr Cancer; 2017; 69(2):177-183. PubMed ID: 28094552
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term stabilization of stage 4 colon cancer using sodium dichloroacetate therapy.
    Khan A; Andrews D; Blackburn AC
    World J Clin Cases; 2016 Oct; 4(10):336-343. PubMed ID: 27803917
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Therapeutic applications of dichloroacetate and the role of glutathione transferase zeta-1.
    James MO; Jahn SC; Zhong G; Smeltz MG; Hu Z; Stacpoole PW
    Pharmacol Ther; 2017 Feb; 170():166-180. PubMed ID: 27771434
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Targeting Cancer Metabolism - Revisiting the Warburg Effects.
    Tran Q; Lee H; Park J; Kim SH; Park J
    Toxicol Res; 2016 Jul; 32(3):177-93. PubMed ID: 27437085
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Dichloroacetate--a healing toxin or a toxic drug?].
    Senderowska Z; Hebanowska A; Sein Anand J; Rybakowska I
    Przegl Lek; 2015; 72(9):479-81. PubMed ID: 26827572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.